Around 50 controlled trials have tested benzodiazepines in depression, and the results are surprising. In this episode we look at the controversies surrounding this research and what it means for practice.
Overdose deaths have been rising during COVID, but simply stopping the drug causes problems of its own. In this podcast, Ashwin Patkar and Richard Weisler discuss how to reduce the risk of opioid deaths in psychiatric patients.
Swapnil Gupta, author of Deprescribing in Psychiatry, shares tips on how to help patients taper off benzodiazepines and psychostimulants in this podcast. She adds a special therapeutic ingredient, but it’s not a medication. Then we digress into one of the oldest medications known to humankind: Opium.
How long does it take for benzos and sleep meds to leave your body? With these sedatives, the question matters…